Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AtriCure, Inc.ATRC · Entity 2704 | Chief Technical Officer | September 23, 2026 | September 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AtriCure, Inc.
Report date September 23, 2026 · Filed September 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 142,745 |
Reported balance
After 2026-09-23 transaction · row 1
1 source rowRow 1 · 2026-09-23 · Sale · Disposed 4,519 · Balance 142,745 F1: These shares were sold pursuant to a 10b5-1 trading plan adopted on February 20, 2026 |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were sold pursuant to a 10b5-1 trading plan adopted on February 20, 2026
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 23, 2026 Filed Sep 24, 2026 21:00 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 4,519 | $60.00 | $271,140.00 |
DisclosureSEC source: 0001336063-26-000010 · wk-form4_1790283650.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 142,745 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan adopted on February 20, 2026 Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 13:18 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 3,657 | $55.00 | $201,135.00 |
DisclosureSEC source: 0001336063-26-000008 · wk-form4_1789046280.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 147,264 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan adopted on February, 20, 2026. Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 11:39 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 7,763 | $52.50 | $407,557.50 |
DisclosureSEC source: 0001336063-26-000006 · wk-form4_1788521967.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 150,921 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan adopted on February 20, 2026. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 12:58 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 636 | $23.78 | $15,124.08 |
DisclosureSEC source: 0001336063-26-000004 · wk-form4_1782997077.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,684 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2026. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2026, which is the last trading day of the applicable offering period. The closing price on June 30, 2026, was $27.98. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:53 UTC | AtriCure, Inc. ATRC · Entity 2704 | Tax withholdingCommon Stock | 13,127 | $31.26 | $410,350.02 |
DisclosureSEC source: 0001336063-26-000002 · wk-form4_1772574779.xml · nonDerivative · entry 3 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,048 F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:53 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 15,198 | $0.00 | $0.00 |
DisclosureSEC source: 0001336063-26-000002 · wk-form4_1772574779.xml · nonDerivative · entry 2 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,175 F2 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:53 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 30,390 | $0.00 | $0.00 |
DisclosureSEC source: 0001336063-26-000002 · wk-form4_1772574779.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,977 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 12:49 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 822 | $25.84 | $21,240.48 |
DisclosureSEC source: 0001323885-25-000079 · wk-form4_1751460533.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,587 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2025. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 2, 2025, which is the first trading day of the applicable offering period. The closing price on January 2, 2025 was $30.40. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 22:01 UTC | AtriCure, Inc. ATRC · Entity 2704 | Tax withholdingCommon Stock | 8,397 | $38.74 | $325,299.78 |
DisclosureSEC source: 0001323885-25-000024 · wk-form4_1741125658.xml · nonDerivative · entry 3 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,765 F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 22:01 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 6,579 | $0.00 | $0.00 |
DisclosureSEC source: 0001323885-25-000024 · wk-form4_1741125658.xml · nonDerivative · entry 2 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,162 F2 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 22:01 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 22,586 | $0.00 | $0.00 |
DisclosureSEC source: 0001323885-25-000024 · wk-form4_1741125658.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,583 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 20:25 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 707 | $19.35 | $13,680.45 |
DisclosureSEC source: 0001323885-24-000098 · wk-form4_1719951929.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,997 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2024. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 28, 2024, which is the last trading day of the applicable offering period. The closing price on June 28, 2024 was $22.77. Read SEC document |
| May 30, 2024 Filed May 31, 2024 20:12 UTC | AtriCure, Inc. ATRC · Entity 2704 | PurchaseCommon Stock | 5,000 | $22.25 | $111,250.00 |
DisclosureSEC source: 0001323885-24-000087 · wk-form4_1717186344.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,290 Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:43 UTC | AtriCure, Inc. ATRC · Entity 2704 | Tax withholdingCommon Stock | 7,354 | $36.28 | $266,803.12 |
DisclosureSEC source: 0001323885-24-000031 · wk-form4_1709674990.xml · nonDerivative · entry 3 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,290 F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:43 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 7,133 | $0.00 | $0.00 |
DisclosureSEC source: 0001323885-24-000031 · wk-form4_1709674990.xml · nonDerivative · entry 2 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,644 F2 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:43 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 19,294 | $0.00 | $0.00 |
DisclosureSEC source: 0001323885-24-000031 · wk-form4_1709674990.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,511 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant. Read SEC document |
| June 30, 2023 Filed Jul 3, 2023 12:19 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 557 | $38.11 | $21,227.27 |
DisclosureSEC source: 0001323885-23-000085 · wk-form4_1688386782.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,217 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2023. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 3, 2023, which is the first trading day of the applicable offering period. The closing price on January 3, 2023 was $44.84. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:17 UTC | AtriCure, Inc. ATRC · Entity 2704 | Tax withholdingCommon Stock | 6,314 | $38.81 | $245,046.34 |
DisclosureSEC source: 0001323885-23-000033 · wf-form4_167788181929046.xml · nonDerivative · entry 3 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,660 F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:17 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 16,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001323885-23-000033 · wf-form4_167788181929046.xml · nonDerivative · entry 2 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,974 F2 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:17 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 8,036 | $0.00 | $0.00 |
DisclosureSEC source: 0001323885-23-000033 · wf-form4_167788181929046.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,870 F1 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had both a Company performance goal and a service period requirement, which were both met. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 20:23 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 350 | $34.73 | $12,155.50 |
DisclosureSEC source: 0001323885-22-000091 · wf-form4_165705255035232.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,834 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2022. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2022, which is the last trading day of the applicable offering period. The closing price on June 30, 2022 was $40.86. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:29 UTC | AtriCure, Inc. ATRC · Entity 2704 | Tax withholdingCommon Stock | 6,700 | $69.59 | $466,253.00 |
DisclosureSEC source: 0001323885-22-000022 · wf-form4_164634295993514.xml · nonDerivative · entry 3 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,484 F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:29 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 6,825 | $0.00 | $0.00 |
DisclosureSEC source: 0001323885-22-000022 · wf-form4_164634295993514.xml · nonDerivative · entry 2 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,184 F2 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:29 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 7,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001323885-22-000022 · wf-form4_164634295993514.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,359 F1 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had both a Company performance goal and a service period requirement, which were both met. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 13:43 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 151 | $59.10 | $8,924.10 |
DisclosureSEC source: 0001209191-22-000390 · doc4.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,570 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended December 31, 2021. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on December 31, 2021, which was the last trading day of the applicable offering period. The closing price on December 31, 2021 was $69.53. Read SEC document |
| July 30, 2021 Filed Aug 3, 2021 12:11 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 8,808 | $85.00 | $748,680.00 |
DisclosureSEC source: 0001209191-21-049167 · doc4.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,419 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. Read SEC document |
| July 28, 2021 Filed Jul 30, 2021 12:41 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 8,000 | $82.50 | $660,000.00 |
DisclosureSEC source: 0001209191-21-048737 · doc4.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,227 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. Read SEC document |
| July 20, 2021 Filed Jul 22, 2021 20:34 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 2,000 | $80.00 | $160,000.00 |
DisclosureSEC source: 0001209191-21-047752 · doc4.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,227 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:10 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 171 | $45.72 | $7,818.12 |
DisclosureSEC source: 0001209191-21-044923 · doc4.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,227 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2021. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 4, 2021, which was the first trading day of the applicable offering period. The closing price on January 4, 2021 was $53.79. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 23:20 UTC | AtriCure, Inc. ATRC · Entity 2704 | Tax withholdingCommon Stock | 8,819 | $66.31 | $584,787.89 |
DisclosureSEC source: 0001209191-21-017223 · doc4.xml · nonDerivative · entry 3 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,056 F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 23:20 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 4,901 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-017223 · doc4.xml · nonDerivative · entry 2 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,875 F2 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 23:20 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 6,528 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-017223 · doc4.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,974 F1 · price: The Reporting person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Equity Incentive Plan. The award had both a Company performance goal and a service period requirement, which were both met. Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 13:22 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 184 | $38.48 | $7,080.32 |
DisclosureSEC source: 0001209191-21-000011 · doc4.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,446 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended December 31, 2020. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 1, 2020, which was the first trading day of the applicable offering period. The closing price on July 1, 2020 was $45.27. Read SEC document |
| December 17, 2020 Filed Dec 21, 2020 22:03 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 10,654 | $51.33 | $546,869.82 |
DisclosureSEC source: 0001209191-20-064673 · doc4.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,262 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $50.00 to $52.50 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 09, 2020 Filed Dec 11, 2020 12:52 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 3,846 | $47.50 | $182,685.00 |
DisclosureSEC source: 0001209191-20-062842 · doc4.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,916 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 11:58 UTC | AtriCure, Inc. ATRC · Entity 2704 | Tax withholdingCommon Stock | 6,596 | $44.59 | $294,115.64 |
DisclosureSEC source: 0001209191-20-043799 · doc4.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,762 F1 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 20:40 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 503 | $28.11 | $14,139.33 |
DisclosureSEC source: 0001209191-20-040372 · doc4.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,358 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2020. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 1, 2020, which was the first trading day of the applicable offering period. The closing price on January 1, 2020 was $33.07. Read SEC document |
| March 01, 2020 Filed Mar 3, 2020 21:12 UTC | AtriCure, Inc. ATRC · Entity 2704 | Tax withholdingCommon Stock | 4,743 | $38.42 | $182,226.06 |
DisclosureSEC source: 0001209191-20-015114 · doc4.xml · nonDerivative · entry 2 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,855 F2 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award. Read SEC document |
| March 01, 2020 Filed Mar 3, 2020 21:12 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 8,459 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-015114 · doc4.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,598 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:27 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 108 | $25.99 | $2,806.92 |
DisclosureSEC source: 0001209191-20-000967 · doc4.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,139 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended December 31, 2019. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 1, 2019, which was the first trading day of the applicable offering period. The closing price on July 1, 2019 was $30.58. Read SEC document |
| July 24, 2019 Filed Jul 26, 2019 11:38 UTC | AtriCure, Inc. ATRC · Entity 2704 | Tax withholdingCommon Stock | 6,596 | $32.52 | $214,501.92 |
DisclosureSEC source: 0001209191-19-043292 · doc4.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,031 F1 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award. Read SEC document |
| June 30, 2019 Filed Jul 3, 2019 01:18 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 717 | $25.36 | $18,183.12 |
DisclosureSEC source: 0001209191-19-040617 · doc4.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,627 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2019. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 28, 2019, which was the last trading day of the applicable offering period. The closing price on June 28, 2019 was $29.84. Read SEC document |
| March 01, 2019 Filed Mar 6, 2019 11:07 UTC | AtriCure, Inc. ATRC · Entity 2704 | Tax withholdingCommon Stock | 3,212 | $30.77 | $98,833.24 |
DisclosureSEC source: 0001209191-19-017217 · doc4.xml · nonDerivative · entry 2 Privitera Salvatore · CIK 0001336063 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,910 F2 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award. Read SEC document |
| March 01, 2019 Filed Mar 6, 2019 11:07 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 10,562 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-017217 · doc4.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,122 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 12:51 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 732 | $24.00 | $17,568.00 |
DisclosureSEC source: 0001209191-19-000618 · doc4.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,560 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended December 31, 2018. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 2, 2018, which was the first trading day of the applicable offering period. The closing price on July 2, 2018 was $28.24. Read SEC document |
| July 24, 2018 Filed Jul 26, 2018 12:35 UTC | AtriCure, Inc. ATRC · Entity 2704 | Tax withholdingCommon Stock | 4,346 | $28.49 | $123,817.54 |
DisclosureSEC source: 0001209191-18-043987 · doc4.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,828 F1 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:20 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 21,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-016428 · doc4.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,174 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant. Read SEC document |
| July 24, 2017 Filed Jul 25, 2017 21:02 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-046206 · doc4.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,000 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. Amended and Restated 2014 Stock Incentive Plan. The shares will vest 25% annually over four years from date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.